COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS APPLICATION IN PREVENTION AND / OR TREATMENT OF RESPIRATORY PATHOLOGIES AND / OR INFECTIONS AND IN IMPROVING THE INTESTINAL FUNCTION

摘要

1. The use of a composition comprising a mixture of probiotic bacteria for the manufacture of a medicament for the prophylactic and / or therapeutic treatment of respiratory pathologies and / or infections; or to simultaneously improve and / or regularize the function of the intestines of the body; or for the manufacture of an influenza vaccine, said mixture comprising the following three bacterial species: Bifidobacterium lactis, Lactobacillus casei subspecies rhamnosus, Lactobacillus plantarum. 2. The use according to claim 1, where the bacterial strains belonging to these bacterial species are selected from: Bifidobacterium lactis, identification number LMG P-21384; Lactobacillus casei subspecies rhamnosus, identification number DSM 16605; Lactobacillus plantarum, identification number LMG P-21021; Lactobacillus plantarum, identification number LMG P-21020; Lactobacillus plantarum, identification number LMG P-21022; Lactobacillus plantarum, identification number LMG P-21023.3. The use according to claim 1, wherein said composition further comprises at least one prebiotic selected from fructo-oligosaccharides, short-chain fructo-oligosaccharides, inulin, isomaltooligosaccharides, pectins, galactooligosaccharides, arabinogalactan, xylo-oligosaccharides, chitosanolanogluanoganosanigluanosanigolanosano , guar, arabian, xanthan gum, modified and resistant starches, polydextrose, D-tagatose; preferably short chain fructooligosaccharides. 4. The use according to claim 1, wherein said composition further comprises at least one probiotic selected from bacterial species: Bifidobacterium adolescentis, Bifidobacterium angulatum, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breveidifidififactum Bifidobacterium catenulatum dentifactidifum bifidobacterium catenulatum dentifactum